Merck, the renowned US pharmaceuticals giant known as MSD across Europe, has abandoned plans for a £1 billion research centre in London—a significant blow for the UK life sciences sector.
Merck, the renowned US pharmaceuticals giant known as MSD across Europe, has abandoned plans for a £1 billion research centre in London—a significant blow for the UK life sciences sector.
A leading biopharmaceutical business saw its shares tumble by almost 40 per cent after results from a trial of its much-anticipated weight loss pill failed to meet market expectations. Viking






